Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 7.875 7.50 8.25 7.875 7.875 7.88 83,819 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.0 -1.5 -0.5 - 30

Eden Research Share Discussion Threads

Showing 9651 to 9674 of 9850 messages
Chat Pages: 394  393  392  391  390  389  388  387  386  385  384  383  Older
DateSubjectAuthorDiscuss
19/10/2020
09:23
What's with the sudden break-out of the share price ... Something is leaking...?
spadeychops
15/10/2020
10:31
Looks like Swedish Noir's Right-ones are in a hurry. UMM..I wonder what is coming?
supersonico
14/10/2020
10:56
Interesting. HL coming in strong as nominees, I suspect.
woolybanana
14/10/2020
07:44
NUMBER OF AIM SECURITIES IN ISSUE As of 21 August 2020, the number of shares in issue was 380,340,229. SIGNIFICANT SHAREHOLDERS As of 21 August 2020, significant shareholdings in the share capital of Eden Research plc were: BGF Investment Management Limited 58,333,000 15.34% Sipcam Oxon S.p.A. 37,614,830 9.89% Hargreaves Lansdown 30,276,493 7.96% Gresham House Asset Management Limited 27,845,445 7.32% Canaccord Genuity Group Inc 22,684,000 5.94% JM Finn Nominees Limited 21,774,435 5.72% Amati AIM VCT plc 16,937,750 4.45% Rathbone Nominees Limited 16,246,373 4.27% HSBC Global Custody Nominee (UK) Limited 14,007,734 3.68% Interactive Investor 12,992,073 3.42% hTTps://www.edenresearch.com/investors/securities_information.aspx ..................... SIGNIFICANT SHAREHOLDERS As of 24 March 2020, significant shareholdings in the share capital of Eden Research plc were: BGF Investment Management Limited 58,333,000 15.34% Sipcam Oxon S.p.A. 37,614,830 9.89% Gresham House Asset Management Limited 27,845,445 7.32% Cannacord Genuity Group Inc 22,684,000 5.96% Amati AIM VCT plc 16,937,750 4.45% Rathbone Nominees Limited 16,670,800 4.38% HSBC Global Custody Nominee (UK) Limited 14,015,588 3.69% JM Finn Nominees Limited 13,939,430 3.66% hTTps://www.edenresearch.com/investors/securities_information.aspx
supersonico
13/10/2020
07:58
On a lighter note... London’s Legendary Hungarian Restaurant ‘Gay Hussar’ Reopens Under New Name ‘Noble Rot’ Or as the locals fondly call it .........."The Furry Fungus"
33mick
13/10/2020
07:05
What dynamic language they use: Edens’address has changed with immediate effect! Surely they mean the address has changed with in short order.
chrischas
13/10/2020
06:16
RNS Today: Well well, not content with buying new office chairs, they’ve moving them to the new office. That should boost the share price Sales anyone?
erinvale
11/10/2020
22:00
Rear View mirror..news United Kingdom June 21, 2018 Eden's Chairman, Lykele van der Broek, made the following statement: “I am delighted to be Chairing my first AGM for Eden at such an exciting time in the Company’s evolution. Since retiring from Bayer CropScience, I have sought out just a few companies in which I could take an interest in and spend time challenging and supporting the executive team to grow and develop their businesses using my experience, and so I was pleased to be offered the role of Chairman at Eden as, after careful consideration, I felt that this business had a lot of potential as well as synergy with my professional background. It seems to me that Eden has invested a significant amount of time and resource to get to where it has got to today and that this is now starting to pay off with commercialisation in full-swing. In short order, we will see crop protection, animal health and consumer products on the market, all of which have been either developed by Eden itself, or by partners using Eden’s terpene and Sustaine├ö encapsulation technologies. Sustaine clearly has such a wide-variety of applications, which is excellent, however, I think the approach being taken by the Company to concentrate its efforts on a handful of different market sectors, initially, is sensible. Over the coming year, I hope to oversee an increase in revenue along with an increase in research and development activity which will help to advance the Company’s product pipeline apace. In addition, I will assist management in expanding the core team so as to effectively manage the increase in activities that we are seeing, as well as using my experience to progress commercial activity, as appropriate. In the longer term, I will strive to help Eden become a significant player in the crop protection, animal health and consumer products sectors, which I believe it can be.” hTTps://www.seedquest.com/news.php?type=news&id_article=99149&id_region=&id_category=
supersonico
11/10/2020
14:55
I guess it will go next to a positive Corteva RNS as implied in the last Proactive video thus allowing Eden to gear up for the present and the future. There are lots of positive indicators from Eden, even if they're not well communicated and understood. If they were, we would not be sat at 7p, but many multiples of the same.
investingisatrickygame
11/10/2020
14:12
New office chairs, new senior analyst, where will Eden go next. Beyond imagining. Perhaps they might even sell some product!
erinvale
11/10/2020
11:30
And a "Senior" analyst. Is there more to follow?
investingisatrickygame
11/10/2020
09:56
Another new face @EDEN. Emma Searson Senior Analyst at Eden Research plc hTTps://www.linkedin.com/in/emma-searson-7ab05254/?miniProfileUrn=urn%3Ali%3Afs_miniProfile%3AACoAAAtlpvMBf0ABQ7ATHwWwtROc0tJMZbSrKNY
supersonico
11/10/2020
09:05
My comment was ‘tongue-in-cheek’. I sincerely hope that Eden delivers for its long-suffering shareholders.
erinvale
11/10/2020
09:00
Erinvale Eden is on RNS with the potential Corteva annual values so it's hard not to make my assumptions
investingisatrickygame
11/10/2020
08:29
Investing: if Eden's office chairs were made of solid gold, they would probably not notice. The most likely would be an RNS about the quality of their doorknocker.
erinvale
11/10/2020
08:13
NEW MSDS AVAILABLE GERANIOL BIOCIDE PUR TT September 30, 2020 New MSDS for Geraniol Biocide Pur TT Consequences for the labelling of your Product. As part of the review, a harmonized classification of the substance hTTps://www.terpenetech.eu/new-msds-available/
supersonico
10/10/2020
22:45
Here is something to think about The Corteva Agreement "The Directors estimate that, if successful, there is the opportunity to generate up to c. €40 million of revenue for Eden from European geographies alone (current market) from this product." Source: Placing RNS 28/2/2020 https://bit.ly/3nC9vFv What is a Unicorn company? A unicorn is a privately held startup company which is valued at over $1 billion(currently equivalent to around £760m). Such companies are classified as unicorns due to the rarity of startups who achieve this significant success and still remain private. Look at these UK unicorn companies and look at their latest turnover in relation to unicorn status hxxps://www.beauhurst.com/research/unicorn-companies/ Also, look at Cazoo hxxps://www.cazoo.co.uk/press/cazoo-reaches-unicorn-status-in-record-time/ "the fastest ever British business to reach unicorn status". Although Eden is a public company and not a private company, a few things strike me about the possibility of Eden valuing at £1 billion/£766 million pounds and yes, 28x Eden's current market cap. 1) The Corteva deal, if successful and if Eden were to trade on a modest 20x times earnings would arguably take Eden over half-way there. With Eden being tech driven, this should in my opinion be quite realistic 2) In the link provided for UK unicorns, some of those companies turnover is a pittance, so the Corteva deal alone could justify Eden reaching half that status IF the investment community understood the additional forward potential 3) Eden has global reach and Cazoo, a car re-seller, is based to the best of my knowledge on a UK market It is going to be a very interesting period for Eden between now and Christmas and should surely/hopefully, set the scene for a significant revaluation of the Company. AND all the other regulatory approvals and subsequent sales will only build more value going forward.
investingisatrickygame
09/10/2020
10:39
Unmentionable. .Vineyard Life . hTTps://www.edenresearch.com/food_for_thought/13/partnering_with_research_excellence_in_uk_viticulture hTTps://www.forbes.com/sites/kristinstoller/2020/10/09/meet-billionaire-politician-tom-steyers-wife-a-pioneering-impact-investor-on-a-mission-to-spend-1-billion-righting-societys-wrongs/#12ab96151aae
supersonico
09/10/2020
10:26
Investing, This recent publication of this patent looks like an evolution and/or final iteration of a patent that started it's IP life in 2007. It adds to the jigsaw of enhanced IP that we have seen recently which has also been the subject of an RNS and post 7722. This also follows the pattern of 2020 where a further four Patents have received updated status, be it regional approval or technical conclusion or both. This resolution adds to my impression of progress which together with Unmentionables mention of the jazzy catchy 'in not too much time' and the imminent Corteva deal makes me cautiously optimistic.
supersonico
09/10/2020
10:09
super What are you taking from that link that is imminent?
investingisatrickygame
08/10/2020
06:12
Unmentionable Ducks in line Tectonic Movement TERPENE-CONTAINING COMPOSITIONS AND METHODS OF MAKING AND USING THEM hTTps://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&;ND=3&adjacent=true&locale=en_EP&FT=D&date=20201008&CC=US&NR=2020315169A1&KC=A1
supersonico
07/10/2020
19:49
SuperPity Mrs100k wasn't seen buying today. Maybe, Mr100k has pulled the plug & prevented her from getting some more cheap shares!
northwick
06/10/2020
17:59
Mrs100k in a hurry I see.
supersonico
04/10/2020
13:57
I'm inclined to agree with your optimistic sentiment Investing but as you will note from our TT experience and to a degree Eastman, time lines are very elastic and it's always been about managing the investor with inthecoming-months opaque narratives instead of inthecoming-years so until Unmentionable puts serious numbers and dates on what he expects Eden will see in revenue terms..it's all Jam because it always has been.
supersonico
Chat Pages: 394  393  392  391  390  389  388  387  386  385  384  383  Older
ADVFN Advertorial
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201203 02:04:54